+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
GI Stool Testing Market by Product, Test, Application, End-use - Global Forecast 2025-2030- Product Image
GI Stool Testing Market by Product, Test, Application, End-use - Global Forecast 2025-2030- Product Image
Sale

GI Stool Testing Market by Product, Test, Application, End-use - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 190 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5977951
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The GI Stool Testing Market grew from USD 651.69 million in 2023 to USD 691.83 million in 2024. It is expected to continue growing at a CAGR of 6.67%, reaching USD 1.02 billion by 2030.

The GI stool testing market involves diagnostic procedures that analyze fecal samples to identify infections, inflammations, and other gastrointestinal (GI) tract conditions. It plays a crucial role in detecting conditions like colorectal cancer, inflammatory bowel disease (IBD), and infections caused by bacteria, viruses, or parasites. The necessity for GI stool testing stems from rising incidences of GI diseases globally, often linked to lifestyle changes and dietary habits, underscoring a growing demand for early diagnosis and effective treatment plans. Its application spans hospitals, diagnostic centers, and research laboratories, serving both preventative and diagnostic needs. Market growth is significantly influenced by factors such as increasing awareness of the significance of early disease detection, advancements in molecular diagnostics, and supportive governmental healthcare policies. Yet, challenges persist, including high costs associated with advanced testing technologies and stringent regulatory standards that can delay the introduction of novel tests. Moreover, the market's growth can be limited by a lack of awareness in developing regions. Among the potential opportunities are innovations in non-invasive testing technologies, which could significantly enhance patient compliance and expand market reach. Advanced biomarker discoveries and the integration of artificial intelligence in diagnostic pathways present further opportunities for enhanced accuracy and efficiency. Companies could focus on telehealth solutions and home-testing kits that cater to the growing trend of personalized healthcare. However, thorough research and strategic partnerships will be necessary to navigate market challenges. Despite these difficulties, the GI stool testing market remains dynamic, with significant untapped potential in personalized medicine and digital health platforms, promoting both consumer convenience and deeper clinical insights. Companies should prioritize innovation in test accuracy, speed, and user accessibility to capture emerging market segments effectively.

Understanding Market Dynamics in the GI Stool Testing Market

The GI Stool Testing Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Rising incidences of gastrointestinal disorders and diseases across the world
    • Efforts by governments and foundations to raise awareness for gastrointestinal health
  • Market Restraints
    • Issues associated with product recalls in GI stool testing
  • Market Opportunities
    • Technological advancements in GI stool testing methods to develop more accurate and less invasive tools
    • Reforms and supportive measures in healthcare policies
  • Market Challenges
    • Challenges with product standardization and compatibility

Exploring Porter’s Five Forces for the GI Stool Testing Market

Porter’s Five Forces framework further strengthens the insights of the GI Stool Testing Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the GI Stool Testing Market

External macro-environmental factors deeply influence the performance of the GI Stool Testing Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the GI Stool Testing Market

The GI Stool Testing Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the GI Stool Testing Market

The GI Stool Testing Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the GI Stool Testing Market

The GI Stool Testing Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the GI Stool Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Bio-Rad Laboratories, Inc., bioMérieux SA, Cardinal Health, Cenogenics Corporation, CTK Biotech, Inc., Danaher Corporation, Diagnostic Solutions Laboratory, LLC, DiaSorin S.p.A., Eiken Chemical Co., Ltd., Emes Software, LLC, Epitope Diagnostics Inc., Geisinger Medical Laboratories, Genova Diagnostics Inc., Helena Laboratories Corporation, Hologic Inc., Lauriston Laboratories Ltd, Meridian Bioscience Inc., Pinnacle BioLabs, Polymedco, LLC, Quest Diagnostics, QuidelOrtho Corporation, ScheBo Biotech AG, and Siemens Healthineers.

Market Segmentation & Coverage

This research report categorizes the GI Stool Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product
    • Analyzers
    • Consumables
  • Test
    • Bacteria Test
    • Fecal Biomarkers Test
      • Transferrin Assays
      • Tumor M2-PK Stool Test
    • Occult Blood Test
      • Guaiac FOB Stool Test
      • Immuno FOB Agglutination Test
      • Immuno FOB ELISA Test
      • Lateral Flow Immuno FOB Test
    • Ova and Parasites Test
  • Application
    • Cancer
    • Gastroesophageal Reflux Disease
    • Infection
    • Inflammatory Bowel Disease
  • End-use
    • Diagnostic Centers
    • Homecare Settings
    • Hospitals & Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising incidences of gastrointestinal disorders and diseases across the world
5.1.1.2. Efforts by governments and foundations to raise awareness for gastrointestinal health
5.1.2. Restraints
5.1.2.1. Issues associated with product recalls in GI stool testing
5.1.3. Opportunities
5.1.3.1. Technological advancements in GI stool testing methods to develop more accurate and less invasive tools
5.1.3.2. Reforms and supportive measures in healthcare policies
5.1.4. Challenges
5.1.4.1. Challenges with product standardization and compatibility
5.2. Market Segmentation Analysis
5.2.1. Product: Preference towards GI stool analyzers due to their speed and accuracy in diagnostics
5.2.2. End-Users: Expanding application of GI Stool Testing in diagnostic centers
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. GI Stool Testing Market, by Product
6.1. Introduction
6.2. Analyzers
6.3. Consumables
7. GI Stool Testing Market, by Test
7.1. Introduction
7.2. Bacteria Test
7.3. Fecal Biomarkers Test
7.3.1. Transferrin Assays
7.3.2. Tumor M2-PK Stool Test
7.4. Occult Blood Test
7.4.1. Guaiac FOB Stool Test
7.4.2. Immuno FOB Agglutination Test
7.4.3. Immuno FOB ELISA Test
7.4.4. Lateral Flow Immuno FOB Test
7.5. Ova and Parasites Test
8. GI Stool Testing Market, by Application
8.1. Introduction
8.2. Cancer
8.3. Gastroesophageal Reflux Disease
8.4. Infection
8.5. Inflammatory Bowel Disease
9. GI Stool Testing Market, by End-use
9.1. Introduction
9.2. Diagnostic Centers
9.3. Homecare Settings
9.4. Hospitals & Clinics
10. Americas GI Stool Testing Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific GI Stool Testing Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa GI Stool Testing Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. FDA Approval of ColoSense, A Breakthrough in Noninvasive Colorectal Cancer Screening
13.3.2. Evaluation of ColoTest, A Consumer-Friendly, At-Home Screening Tool for Early Detection of Gastrointestinal Conditions
13.3.3. Geneoscopy and Labcorp Partnership Elevates Access to Innovative Colorectal Cancer Screening
13.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. GI STOOL TESTING MARKET RESEARCH PROCESS
FIGURE 2. GI STOOL TESTING MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL GI STOOL TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL GI STOOL TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL GI STOOL TESTING MARKET SIZE, BY TEST, 2023 VS 2030 (%)
FIGURE 9. GLOBAL GI STOOL TESTING MARKET SIZE, BY TEST, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 11. GLOBAL GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL GI STOOL TESTING MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
FIGURE 13. GLOBAL GI STOOL TESTING MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES GI STOOL TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES GI STOOL TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. GI STOOL TESTING MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. GI STOOL TESTING MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. GI STOOL TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL GI STOOL TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL GI STOOL TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GI STOOL TESTING MARKET DYNAMICS
TABLE 7. GLOBAL GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL GI STOOL TESTING MARKET SIZE, BY ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL GI STOOL TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL GI STOOL TESTING MARKET SIZE, BY BACTERIA TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL GI STOOL TESTING MARKET SIZE, BY TRANSFERRIN ASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL GI STOOL TESTING MARKET SIZE, BY TUMOR M2-PK STOOL TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL GI STOOL TESTING MARKET SIZE, BY GUAIAC FOB STOOL TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL GI STOOL TESTING MARKET SIZE, BY IMMUNO FOB AGGLUTINATION TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL GI STOOL TESTING MARKET SIZE, BY IMMUNO FOB ELISA TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL GI STOOL TESTING MARKET SIZE, BY LATERAL FLOW IMMUNO FOB TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL GI STOOL TESTING MARKET SIZE, BY OVA AND PARASITES TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL GI STOOL TESTING MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL GI STOOL TESTING MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL GI STOOL TESTING MARKET SIZE, BY INFECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL GI STOOL TESTING MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL GI STOOL TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL GI STOOL TESTING MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL GI STOOL TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 41. ARGENTINA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
TABLE 42. ARGENTINA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 43. ARGENTINA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 44. ARGENTINA GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 46. BRAZIL GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 47. BRAZIL GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 49. BRAZIL GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 51. CANADA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 52. CANADA GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 53. CANADA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
TABLE 54. CANADA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 55. CANADA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. CANADA GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 57. MEXICO GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 58. MEXICO GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 59. MEXICO GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
TABLE 60. MEXICO GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 61. MEXICO GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. MEXICO GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES GI STOOL TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 70. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 72. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
TABLE 73. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 74. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 76. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 77. AUSTRALIA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 78. AUSTRALIA GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 79. AUSTRALIA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
TABLE 80. AUSTRALIA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 81. AUSTRALIA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. AUSTRALIA GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 83. CHINA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 84. CHINA GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 85. CHINA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
TABLE 86. CHINA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 87. CHINA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. CHINA GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 89. INDIA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 90. INDIA GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 91. INDIA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
TABLE 92. INDIA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 93. INDIA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. INDIA GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 95. INDONESIA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 96. INDONESIA GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 97. INDONESIA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
TABLE 98. INDONESIA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 99. INDONESIA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. INDONESIA GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 101. JAPAN GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 102. JAPAN GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 103. JAPAN GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
TABLE 104. JAPAN GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 105. JAPAN GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. JAPAN GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 107. MALAYSIA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 108. MALAYSIA GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 109. MALAYSIA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
TABLE 110. MALAYSIA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 111. MALAYSIA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. MALAYSIA GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 113. PHILIPPINES GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 114. PHILIPPINES GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 115. PHILIPPINES GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
TABLE 116. PHILIPPINES GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 117. PHILIPPINES GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. PHILIPPINES GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 119. SINGAPORE GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 120. SINGAPORE GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 121. SINGAPORE GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
TABLE 122. SINGAPORE GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 123. SINGAPORE GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. SINGAPORE GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 125. SOUTH KOREA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 126. SOUTH KOREA GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 127. SOUTH KOREA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
TABLE 128. SOUTH KOREA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 129. SOUTH KOREA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. SOUTH KOREA GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 131. TAIWAN GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 132. TAIWAN GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 133. TAIWAN GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
TABLE 134. TAIWAN GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 135. TAIWAN GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. TAIWAN GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 137. THAILAND GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 138. THAILAND GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 139. THAILAND GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
TABLE 140. THAILAND GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 141. THAILAND GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. THAILAND GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 143. VIETNAM GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 144. VIETNAM GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 145. VIETNAM GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
TABLE 146. VIETNAM GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 147. VIETNAM GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 148. VIETNAM GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 156. DENMARK GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 157. DENMARK GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 158. DENMARK GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
TABLE 159. DENMARK GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 160. DENMARK GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. DENMARK GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 162. EGYPT GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 163. EGYPT GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 164. EGYPT GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
TABLE 165. EGYPT GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 166. EGYPT GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. EGYPT GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 168. FINLAND GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 169. FINLAND GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 170. FINLAND GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
TABLE 171. FINLAND GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 172. FINLAND GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. FINLAND GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 174. FRANCE GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 175. FRANCE GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 176. FRANCE GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
TABLE 177. FRANCE GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 178. FRANCE GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. FRANCE GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 180. GERMANY GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 181. GERMANY GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 182. GERMANY GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
TABLE 183. GERMANY GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 184. GERMANY GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. GERMANY GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 186. ISRAEL GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 187. ISRAEL GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 188. ISRAEL GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
TABLE 189. ISRAEL GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 190. ISRAEL GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 191. ISRAEL GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 192. ITALY GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 193. ITALY GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 194. ITALY GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
TABLE 195. ITALY GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 196. ITALY GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 197. ITALY GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 198. NETHERLANDS GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 199. NETHERLANDS GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 200. NETHERLANDS GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
TABLE 201. NETHERLANDS GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 202. NETHERLANDS GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 203. NETHERLANDS GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 204. NIGERIA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 205. NIGERIA GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 206. NIGERIA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
TABLE 207. NIGERIA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 208. NIGERIA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 209. NIGERIA GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 210. NORWAY GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 211. NORWAY GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 212. NORWAY GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
TABLE 213. NORWAY GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 214. NORWAY GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 215. NORWAY GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 216. POLAND GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 217. POLAND GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 218. POLAND GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
TABLE 219. POLAND GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 220. POLAND GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 221. POLAND GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 222. QATAR GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 223. QATAR GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 224. QATAR GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
TABLE 225. QATAR GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 226. QATAR GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 227. QATAR GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 228. RUSSIA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 229. RUSSIA GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 230. RUSSIA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
TABLE 231. RUSSIA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 232. RUSSIA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 233. RUSSIA GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 234. SAUDI ARABIA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 236. SAUDI ARABIA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 238. SAUDI ARABIA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 240. SOUTH AFRICA GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 242. SOUTH AFRICA GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 244. SOUTH AFRICA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 246. SPAIN GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 247. SPAIN GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 248. SPAIN GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
TABLE 249. SPAIN GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 250. SPAIN GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 251. SPAIN GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 252. SWEDEN GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 253. SWEDEN GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 254. SWEDEN GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
TABLE 255. SWEDEN GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 256. SWEDEN GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 257. SWEDEN GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
TABLE 261. SWITZERLAND GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 262. SWITZERLAND GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 263. SWITZERLAND GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 264. TURKEY GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 265. TURKEY GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 266. TURKEY GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
TABLE 267. TURKEY GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 268. TURKEY GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 269. TURKEY GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 276. UNITED KINGDOM GI STOOL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM GI STOOL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 278. UNITED KINGDOM GI STOOL TESTING MARKET SIZE, BY FECAL BIOMARKERS TEST, 2018-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM GI STOOL TESTING MARKET SIZE, BY OCCULT BLOOD TEST, 2018-2030 (USD MILLION)
TABLE 280. UNITED KINGDOM GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM GI STOOL TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 282. GI STOOL TESTING MARKET SHARE, BY KEY PLAYER, 2023
TABLE 283. GI STOOL TESTING MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the GI Stool Testing market, which are profiled in this report, include:
  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • Cardinal Health
  • Cenogenics Corporation
  • CTK Biotech, Inc.
  • Danaher Corporation
  • Diagnostic Solutions Laboratory, LLC
  • DiaSorin S.p.A.
  • Eiken Chemical Co., Ltd.
  • Emes Software, LLC
  • Epitope Diagnostics Inc.
  • Geisinger Medical Laboratories
  • Genova Diagnostics Inc.
  • Helena Laboratories Corporation
  • Hologic Inc.
  • Lauriston Laboratories Ltd
  • Meridian Bioscience Inc.
  • Pinnacle BioLabs
  • Polymedco, LLC
  • Quest Diagnostics
  • QuidelOrtho Corporation
  • ScheBo Biotech AG
  • Siemens Healthineers

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages190
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 691.83 Million
Forecasted Market Value ( USD ) by 2030 $ 1020 Million
Compound Annual Growth Rate6.6%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

GI Stool Testing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

GI Stool Testing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 117 Pages
  • Global
From
GI Stool Testing Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

GI Stool Testing Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 96 Pages
  • Global
From
Immunodiagnostics Market 2024-2028 - Product Image

Immunodiagnostics Market 2024-2028

  • Report
  • 184 Pages
  • Global
From
Fecal Occult Testing Market by Product, End-User - Global Forecast 2025-2030 - Product Image

Fecal Occult Testing Market by Product, End-User - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
Fecal Occult Testing Market Report by Test Type (Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test, Immuno-FOB ELISA Test), End User (Hospitals, Clinical Diagnostic Laboratories, Physician Office Laboratories), and Region 2024-2032 - Product Image

Fecal Occult Testing Market Report by Test Type (Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test, Immuno-FOB ELISA Test), End User (Hospitals, Clinical Diagnostic Laboratories, Physician Office Laboratories), and Region 2024-2032

  • Report
  • 147 Pages
  • Global
From

About the GI Stool Test Market

The GI Stool Test market within the context of In Vitro Diagnostics is a segment of the medical diagnostics industry that focuses on the detection of gastrointestinal diseases and disorders. It is a rapidly growing market, driven by the increasing prevalence of gastrointestinal diseases and the need for early diagnosis and treatment. GI Stool Tests are used to detect a variety of gastrointestinal conditions, including bacterial infections, parasites, and inflammatory bowel disease. These tests are typically performed in a laboratory setting and can provide valuable information to healthcare providers. The GI Stool Test market is highly competitive, with a number of companies offering a range of products and services. Some of the major players in the market include Quest Diagnostics, LabCorp, Bio-Rad Laboratories, and Genova Diagnostics. Other companies in the market include Eurofins Scientific, Mayo Medical Laboratories, and ARUP Laboratories. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.